Mr Mrs Miss Ms Dr Other

Mr
Matthew
Dean

Patent Attorney

Manchester Office

Chemistry

Telephone. +44(0) 161 247 4900
Email. matthewdean@hgf.com

Experience

Matthew graduated from Newcastle University having obtained an MChem Master of Chemistry with study abroad. Matthew also studied at Ludwig-Maximilians-Universität München in Germany, specialising in improving the efficiency and intensity of OLED technology by designing a catalogue of novel tertiary phosphine ligands for coordination with cheaper, alternative metals, removing the need for reliance on rare earth metals. During his Masters studies, Matthew worked on researching a family of fluorophores known as Boranils, which are commonly used for imaging probes, fluorescent dyes and switches.

Since joining HGF in 2018 as a Trainee Patent Attorney, Matthew has gained experience in patent drafting, prosecution and freedom-to-operate matters in a number of different areas of chemistry. His main focus of expertise is directed to materials chemistry and fluorescent technology but also has experience in pharmaceuticals and medical device technology.

Qualifications

Trainee


MCHEM

MChem with study abroad

POSTGRADUATE DIPLOMA OR CERTIFICATE

PGCert Intellectual Property

Related News

Office Closed Dates December 2025 / January 2026

HGF Office Closed Dates December 2025 / January 2026   UK Thursday 25 and Friday 26 December 2025 CLOSED Thursday 1 January 2026* CLOSED * Friday 2 January 2026 – …

Read article

PRESS RELEASE – HGF strengthens European presence with three new Partners in France and Germany

HGF is pleased to announce the arrival of three new partners, further strengthening its European presence. Two partners will be joining the firm’s fast-growing French practice, and one will join …

Read article

The EPO Board of Appeal comments on the scope of the morality exclusion from patentability

The recent decision, T1553/22 of the Board of Appeal required the Board to consider the scope of the exclusions from patentability under Article 53(a) EPC. The invention in this case …

Read article

The Antibody Series #4 | pH points in antibody claims: when “same pH ” becomes an addition of matter

The Boards of Appeal of the EPO (BoA) are the appeal body that reviews EPO decisions; in this case, they reviewed a revocation in opposition of a patent relating to …

Read article

The Antibody Series #3 | Antibody code names in claims: why “ACZ885” is not sufficient to define the antibody

The Boards of Appeal of the EPO (BoA) are the appeal body that reviews EPO decisions. In this case, they examined a claim that identified an antibody by an internal …

Read article

Agritech Thymes: Unlocking the Soil Microbiome: Driving Agritech Innovation in the UK

The UK offers an ideal platform for harnessing the untapped potential of soil and plant microorganisms. Although much of my professional experience has focused on the human microbiome, I have …

Read article

The Antibody Series #1 | Quality Characteristics (CQAs) in Antibody Claims: When the Test Method Can Remain Outside the Claim

Therapeutic antibodies are at the heart of innovations in biotechnology and healthcare. With increasing regulatory requirements and quality expectations, critical quality attributes (CQAs) are becoming essential in the drafting of …

Read article

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.